Gene Biotherapeutics Inc (CRXM)
0.00
USD |
OTCM |
May 17, 16:00
Gene Biotherapeutics Total Assets (Quarterly): 0.3739M for March 31, 2017
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.567M |
| September 30, 2020 | 0.9748M |
| June 30, 2020 | 1.342M |
| March 31, 2020 | 0.1297M |
| December 31, 2019 | 0.0354M |
| March 31, 2017 | 0.3739M |
| December 31, 2016 | 1.111M |
| September 30, 2016 | 1.954M |
| June 30, 2016 | 0.0246M |
| March 31, 2016 | 0.1318M |
| December 31, 2015 | 0.0373M |
| September 30, 2015 | 0.0468M |
| June 30, 2015 | 0.17M |
| March 31, 2015 | 0.5505M |
| December 31, 2014 | 0.7461M |
| September 30, 2014 | 1.978M |
| June 30, 2014 | 3.406M |
| March 31, 2014 | 2.968M |
| December 31, 2013 | 2.786M |
| September 30, 2013 | 5.129M |
| June 30, 2013 | 5.481M |
| March 31, 2013 | 5.462M |
| December 31, 2012 | 7.809M |
| September 30, 2012 | 9.580M |
| June 30, 2012 | 9.265M |
| Date | Value |
|---|---|
| March 31, 2012 | 11.79M |
| December 31, 2011 | 7.503M |
| September 30, 2011 | 3.953M |
| June 30, 2011 | 5.867M |
| March 31, 2011 | 7.665M |
| December 31, 2010 | 9.512M |
| September 30, 2010 | 9.662M |
| June 30, 2010 | 11.93M |
| March 31, 2010 | 13.79M |
| December 31, 2009 | 5.476M |
| September 30, 2009 | 6.862M |
| June 30, 2009 | 8.666M |
| March 31, 2009 | 10.29M |
| December 31, 2008 | 10.30M |
| September 30, 2008 | 9.052M |
| June 30, 2008 | 13.80M |
| March 31, 2008 | 15.57M |
| December 31, 2007 | 16.93M |
| September 30, 2007 | 17.79M |
| June 30, 2007 | 23.47M |
| March 31, 2007 | 28.00M |
| December 31, 2006 | 14.12M |
| September 30, 2006 | 18.95M |
| June 30, 2006 | 23.55M |
| March 31, 2006 | 26.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0354M
Minimum
Dec 2019
1.342M
Maximum
Jun 2020
0.6097M
Average
0.567M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 278.29M |
| Protalix BioTherapeutics Inc | 89.82M |
| Electromed Inc | 48.90M |
| Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.092M |
| Shareholders Equity (Quarterly) | -3.718M |